Skip to main content
Top
Published in: Rheumatology International 6/2024

Open Access 16-02-2024 | Takayasu's Arteriitis | Observational Research

Poor obstetric outcomes in women with takayasu arteritis: a retrospective cohort study

Authors: Erdal Bodakçi, Döndü Üsküdar Cansu, Cengiz Korkmaz

Published in: Rheumatology International | Issue 6/2024

Login to get access

Abstract

The objective of this study was to assess the pregnancy outcomes in a cohort of patients who experienced pregnancies before and/or after being diagnosed with Takayasu’s arteritis (TA). The present investigation encompassed a total of 88 pregnancies seen in a cohort of 35 patients who met the criteria outlined by the American College of Rheumatology in 1990 for the classification of Takayasu arteritis (TA). Pregnancies were classified into two categories. 1. Pregnancies that occurred before the diagnosis (pre-d or pre-TA) 2. Pregnancies that happened following a diagnosis (post-d or post-TA). Fifty-nine pregnancies (67.0%) occurred in 21 TA patients before the diagnosis with and a complication rate of 15.2%, and twenty-nine pregnancies (33.0%) occurred in 14 patients concomitant with or after TA diagnosis and complication rate 100%. Although the hypertension rate was higher in the pre-d group than in the post-d group, it was not significant (32.2% vs. 10.3%, p = 0.160). However, preeclampsia (20.6% vs. 0%, p = 0.001), low birth weight (27.5% vs. 1.6%, p = 0.001), and prematurity (24.1% vs. 1.6%, p = 0.035) were observed more frequently in the post-d group compared to the pre-d group. The frequency of abortions and in-utero deaths were similar in both groups (p > 0.05). Patients with hypertension had significantly higher rates of preeclampsia (p = 0.003), preterm birth (p = 0.036), low birth weight (p = 0.250), abortion (p = 0.018), in utero death (p = 0.128), and cesarean section (p = 0.005) than those without hypertension. Renal artery involvement was detected in 15 (42.8%) patients. All patients with renal artery involvement had hypertension, and they had significantly more pregnancy complications than the other group (p = 0.001). TA negatively affects pregnancy outcomes. A good control of arterial hypertension before conception and during pregnancy is critical to improve both maternal and fetal outcomes. In addition, detecting renal artery stenosis before pregnancy is important in reducing possible negative pregnancy outcomes.
Literature
14.
go back to reference Siddiqui F, Kean L (2009) Intrauterine fetal death. Obstet Gynaecol Reprod Med 19(1):1–6CrossRef Siddiqui F, Kean L (2009) Intrauterine fetal death. Obstet Gynaecol Reprod Med 19(1):1–6CrossRef
22.
go back to reference David LS, Beck MM, Kumar M, Rajan SJ, Danda D, Vijayaselvi R (2020) Obstetric and perinatal outcomes in pregnant women with Takayasu’s arteritis: single centre experience over five years. J Turk Ger Gynecol Assoc 21(1):15–23CrossRefPubMedPubMedCentral David LS, Beck MM, Kumar M, Rajan SJ, Danda D, Vijayaselvi R (2020) Obstetric and perinatal outcomes in pregnant women with Takayasu’s arteritis: single centre experience over five years. J Turk Ger Gynecol Assoc 21(1):15–23CrossRefPubMedPubMedCentral
25.
go back to reference Eryurt M, Adalı T, Türkyılmaz A, Çağatay P, Koç İ, Çavlin A and Keskin F (2019). Hacettepe University Institute of Population Studies, 2018 Turkey Demographic and Health Survey; T.R. Presidency of Turkey Directorate of Strategy and Budget and TÜBİTAK; Elma Teknik Basım Matbaacılık Ltd. Şti.: Ankara, Turkey, 2019; p. 282. Eryurt M, Adalı T, Türkyılmaz A, Çağatay P, Koç İ, Çavlin A and Keskin F (2019). Hacettepe University Institute of Population Studies, 2018 Turkey Demographic and Health Survey; T.R. Presidency of Turkey Directorate of Strategy and Budget and TÜBİTAK; Elma Teknik Basım Matbaacılık Ltd. Şti.: Ankara, Turkey, 2019; p. 282.
Metadata
Title
Poor obstetric outcomes in women with takayasu arteritis: a retrospective cohort study
Authors
Erdal Bodakçi
Döndü Üsküdar Cansu
Cengiz Korkmaz
Publication date
16-02-2024
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 6/2024
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-024-05538-z

Other articles of this Issue 6/2024

Rheumatology International 6/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine